Viewing Study NCT07279766


Ignite Creation Date: 2025-12-24 @ 4:02 PM
Ignite Modification Date: 2025-12-26 @ 8:50 PM
Study NCT ID: NCT07279766
Status: RECRUITING
Last Update Posted: 2025-12-12
First Post: 2025-11-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effectiveness of mRNA-1273 Variant-Containing Vaccine Formulation Against Severe Outcomes in Adults Aged 50-64 Years Without Risk Factors for Severe COVID-19
Sponsor: Tor Biering-Sørensen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module